Uphealth, Inc.

Safety Score

Market Cap $3.74K
PE -0
Debt $284.12M
Cash $170.34M
EV $113.78M
FCF -$17.47M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$24.34M
EBIT	-$62.23M
ROE	-30%
ROA	-23%
FCF	-$17.47M
Equity	$81.79M
Growth Stability	1
PE	-0
PB	0
P/FCF	-0
P/S	0
Price/Cash	45.57K
Debt/Equity	3.47
Debt/FCF	-16.27
Gross Margins	53%
Op. Margins	-71%
Sales Growth YoY	-100%
Sales Growth QoQ	-100%
Sales CAGR	8%
Equity CAGR	96%
Earnings Growth YoY	-414%

Earnings Growth QoQ	-354%
Sales CAGR 5Y	10%
Equity CAGR 5Y	96%
Earnings CAGR 3Y	16%
Sales CAGR 3Y	16%
Equity CAGR 3Y	-60%
Market Cap	$3.74K
Revenue	$87.85M
Assets	$269.73M
Total Debt	$284.12M
Cash	$170.34M
Shares Outstanding	18.69M
EV	113.78M
Safety Score	59%
Working Capital	26.38M
Current Ratio	1.18
Gross Profit	$46.92M
Shares Growth 3y	30%
Equity Growth QoQ	48%
Equity Growth YoY	-21%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

UpHealth Inc is a global digital health company intent on creating a single, integrated platform of technologies and services essential to personalized, affordable, and effective care globally. The company's segment includes Integrated Care Management; Virtual Care Infrastructure; Services and Corporate. It generates maximum revenue from the Services segment. Geographically, it derives a majority of revenue from the Americas.

SEC Filings

Direct access to Uphealth, Inc. (UPHL) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Uphealth, Inc. compare to its competitors?

Not enough data to generate a comparison chart between Uphealth, Inc. and its competitors. Please check back later.

Peter Lynch's Chart

This chart shows the current pricing of Uphealth, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Uphealth, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Uphealth, Inc..

Years

Calculation mode

= -$175M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$17M	-$17M	-$17M	-$17M	-$17M	-$17M	-$17M	-$17M	-$17M	-$17M	-$17M	-$175M
DCF		-$16M	-$14M	-$13M	-$12M	-$11M	-$9.9M	-$9M	-$8.1M	-$7.4M	-$6.7M	-$67M
Value	-$175M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	03/2019	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	-	-70%	-275%	-140%	-44%	-
ROA	-	-1%	-57%	-47%	-25%	-23%
ROE	-	-2%	-102%	-210%	-105%	-30%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	03/2019	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-	-3.08	-6.23	-7.96	-16.27
Debt over Equity	-	0.21	0.61	1.72	3.13	3.47
Growth Stability	-	-	-	-	-	1

Good Debt/FCF ratio (-16.27)

Net Margins are high enough to offer a good protection on the profits in case of higher costs or higher interests. Furthermore higher margins reduce earnings’ volatility.

Bad Debt/Equity ratio (3.47)

The company is overleveraged and has a bad balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	03/2019	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	-	2K%	28%	-18%	10%
Earnings YoY growth	-	11K%	9K%	-35%	-74%	-
Equity YoY growth	-	-2M%	51%	-68%	-48%	96%
FCF YoY growth	-	-	3K%	-56%	-26%	-